Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, August 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
TELOS MicroPlate™ from Kinesis – a versatile 96-well SPE format for small volume biological fluid samples
Monday, December 16, 2013
The TELOS MicroPlate™ is a versatile 96-well plate for the extraction of drug molecules from small volume biological fluid samples.

Multicapacity Microreactor for Catalyst Characterization
Thursday, December 12, 2013
Hiden Catlab integrated micro-reactor/mass spectrometer system.

AB SCIEX Launches CE Marked IVD-MS™ Analyzer for Hospitals and Diagnostic Laboratories in Europe
Tuesday, November 26, 2013
The first-in-class, complete analyzer is based on LC/MS/MS technology meeting European regulatory requirements.

Cerilliant Introduces Certified Spiking Solution® of Acetyl Fentanyl
Wednesday, November 13, 2013
Cerilliant introduces a Certified Reference Material of acetyl fentanyl in methanol at a concentration of 1.0 mg/mL.

Analysis of Dithiocarbamate Pesticides by GC-MS
Monday, November 11, 2013
Analysis of dithiocarbamate fungicides compares DTC levels in various food samples.

QGA Quantitative Gas Analysis Package
Thursday, November 07, 2013
New QGA Professional gas/vapour analysis software from Hiden.

Tecan Launches AC Extraction Plate™
Wednesday, October 30, 2013
Provides a unique sample preparation tool for LC-MS.

Determination of Phthalates in Liquor by GC-MS
Friday, October 25, 2013
Sensitive, rapid, and accurate method for phthalates detection.

Thermo Scientific Mass Spec User Meetings
Tuesday, October 15, 2013
Guest presenters from Harvard Medical School, Stanford, Michigan State University, Pfizer and Bristol Meyers Squibb and other organizations will describe how they apply the latest high resolution accurate mass spectrometry technology to a variety of challenging life science experiments.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 1092
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv